During the week of January 22-24, 2019 we had the honor to attend the co-located Phacilitate Leaders World and World Stem Cell Summit 2019 conferences in Miami, Florida and host a yacht party fundraiser in partnership with Phacilitate — which raised a total $17,350!
It's our anniversary! It has been four years to the date since we first launched the Emily Whitehead Foundation. Thank you to all who have supported us thus far in our journey.
On January 3, 2019, we began the new year by joining members of our local community at the 4th Annual Take Down Cancer Event benefitting the Emily Whitehead Foundation. Thanks to the combined fundraising efforts of the Philipsburg-Osceola and Clearfield school districts and high school wrestling clubs, this year's event raised a total $11,205 to help further childhood cancer research!
Emily Whitehead Foundation and Phacilitate to Hold Yacht Party Fundraiser at Phacilitate Leaders World in Miami
In an effort to bring more awareness to pediatric cancer immunotherapy research, the Emily Whitehead Foundationand London-based Phacilitate are joining together to hold a one of a kind fundraising event in Miami, Florida on January 24, 2019.
On August 27, the European Commission announced that Novartis CAR-T cell therapy Kymriah has been approved to treat pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in Europe.